Company:  COHERUS BIOSCIENCES, INC. (CHRS)
Form Type:  4
Filing Date:  5/19/2017 
CIK:  0001512762 
Address:  C/O DENNIS M. LANFEAR
333 TWIN DOLPHIN DR, SUITE 600
 
City, State, Zip:  REDWOOD CITY, California 94065 
Telephone:  (650) 649-3530 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.75  
Change: 
-0.60 (-6.42%)  
Trade Time: 
01:00 PM EST  
Market Cap: 
$507.02M
Trade CHRS now with 

© 2017  
Description of Business
We are a late-stage clinical biologics platform company focused on the global biosimilar market. Biosimilars are an emerging class of protein-based therapeutics with high similarity to approved originator products on the basis of various physicochemical and structural properties, as well as in terms of safety, purity and potency. Our goal is to become a global leader in the biosimilar market by leveraging our team's collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. Since our founding in 2010, we have advanced three product candidates into Phase 3 clinical studies or filed for a Biologics License Application (BLA) enabling clinical development, entered into partnerships with two global pharmaceutical companies and entered into an agreement with one strategic biologics manufacturer.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES